Advanced search
Publication Cover
Emerging Microbes & Infections Volume 9, 2020 - Issue 1
Submit an article Journal homepage
2,531
Views
14
CrossRef citations to date
0
Altmetric
Letter

Co-existence of OXA-48 and NDM-1 in colistin resistant Pseudomonas aeruginosa ST235

Cansel Vatansevera Department of Infectious Diseases and Clinical Microbiology, Koc University School of Medicine, Istanbul, Turkey
,
Sirin Menekseb Department of Infectious Diseases and Clinical Microbiology, Kosuyolu State Hospital, Istanbul, Turkey
,
Ozlem Dogana Department of Infectious Diseases and Clinical Microbiology, Koc University School of Medicine, Istanbul, Turkey
,
Lal Sude Gucera Department of Infectious Diseases and Clinical Microbiology, Koc University School of Medicine, Istanbul, Turkey
,
Berna Ozera Department of Infectious Diseases and Clinical Microbiology, Koc University School of Medicine, Istanbul, Turkey
,
Onder Ergonula Department of Infectious Diseases and Clinical Microbiology, Koc University School of Medicine, Istanbul, Turkey
&
Fusun Cana Department of Infectious Diseases and Clinical Microbiology, Koc University School of Medicine, Istanbul, TurkeyCorrespondence[email protected]
[email protected]
 show all
Pages 152-154 | Received 07 Nov 2019, Accepted 30 Dec 2019, Published online: 21 Jan 2020

References

  • Moradali MF, Ghods S, Rehm BH. Pseudomonas aeruginosa lifestyle: a paradigm for adaptation, survival, and persistence. Front Cell Infect Microbiol. 2017;7(39):1–29.
  • Oliver A, Mulet X, Lopez-Causape C, et al. The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist Update. 2015 Jul–Aug;21-22:41–59.
  • European Centre of Diseases Prevention and Control. Surveillence of antimicrobial resistance in Europe. (2016). Anual Report of the European Antimicrobial Resistance Surveillence Network (EARS-NET). Stocholm: ECDC; 2016.
  • Aydin M, Ergonul O, Azap A, et al. Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections. J Hosp Infect. 2018 Mar;98(3):260–263.
  • Wi YM, Choi JY, Lee JY, et al. Emergence of colistin resistance in Pseudomonas aeruginosa ST235 clone in South Korea. Int J Antimicrob Agents. 2017 Jun;49(6):767–769.
  • Lee JY, Ko KS. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates. Diagn Microbiol Infect Dis. 2014 Mar;78(3):271–276.
  • Muggeo A, Guillard T, Klein F, et al. Spread of Klebsiella pneumoniae ST395 non-susceptible to carbapenems and resistant to fluoroquinolones in North-Eastern France. J Glob Antimicrob Re. 2018 Jun;13:98–103.
  • Schwab F, Geffers C, Behnke M, et al. ICU mortality following ICU-acquired primary bloodstream infections according to the type of pathogen: a prospective cohort study in 937 Germany ICUs (2006–2015). PLoS One. 2018;13(3):1–13. e0194210.
  • Gandra S, Tseng KK, Arora A, et al. The mortality burden of multidrug-resistant pathogens in India: a retrospective observational study. Clin Infect Dis. 2018;69(4):563–570.
  • Recio R, Villa J, Viedma E, et al. Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: facing the perfect storm. Int J Antimicrob Agents. 2018 Aug;52(2):172–179.
  • Mohamed SER, Alobied A, Hussien WM, et al. blaOXA-48 carbapenem resistant Pseudomonas aeruginosa clinical isolates in Sudan. Journal of Advances in Microbiology. 2018;10(4):1–5.
  • Jovcic B, Lepsanovic Z, Suljagic V, et al. Emergence of NDM-1 metallo-beta-lactamase in Pseudomonas aeruginosa clinical isolates from Serbia. Antimicrob Agents Chemother. 2011 Aug;55(8):3929–3931.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.